[Translation] A multicenter, randomized, open-label, non-inferiority clinical study comparing the efficacy and safety of recombinant insulin glargine injection and Lantus in the treatment of type 2 diabetes mellitus
主要目的: 评价重组甘精胰岛素注射液与来得时®(甘精胰岛素注射液)治疗2型糖尿病的有效性。 次要目的: 比较重组甘精胰岛素注射液与来得时®(甘精胰岛素注射液)治疗2型糖尿病的安全性。
[Translation] Main objective: To evaluate the efficacy of recombinant insulin glargine injection and Lantus® (insulin glargine injection) in the treatment of type 2 diabetes. Secondary objective: To compare the safety of recombinant insulin glargine injection with Lantus® (insulin glargine injection) in the treatment of type 2 diabetes.